Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Drug Screening for these regions, from 2012 to 2023 (forecast), including
Northeast
Midwest
South
West
USA Drug Screening market competition by top manufacturers/players, with Drug Screening sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Alere
Express Diagnostics
Laboratory Corporation of America
MPD
Quest Diagnostics
Roche Diagnostics
Shimadzu
Siemens Healthcare
Thermo Fisher Scientific
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Immunoassay Analyzers
Chromatography
Breath Analyzers
Rapid Testing Devices
Assay Kits and Reagents
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Drug Screening for each application, including
Hospitals
Research Institute
Biotechnology & Pharmaceutical Companies
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
USA Drug Screening Market Report 2012-2023
1 Drug Screening Overview
1.1 Product Overview and Scope of Drug Screening
1.2 Classification of Drug Screening by Product Category
1.2.1 USA Drug Screening Sales (K Units) Comparison by Types (2012-2023)
1.2.2 USA Drug Screening Sales (K Units) Market Share by Types in 2017
1.2.3 Immunoassay Analyzers
1.2.4 Chromatography
1.2.5 Breath Analyzers
1.2.6 Rapid Testing Devices
1.2.7 Assay Kits and Reagents
1.3 USA Drug Screening Market by Application/End Users
1.3.1 USA Drug Screening (K Units) and Market Share Comparison by Applications (2012-2023)
1.3.2 Hospitals
1.3.3 Research Institute
1.3.4 Biotechnology & Pharmaceutical Companies
1.3.5 Other
1.4 USA Drug Screening Market by Region
1.4.1 USA Drug Screening Revenue (Million USD) Comparison by Regions (2012-2023)
1.4.2 Northeast Status and Prospect (2012-2023)
1.4.3 Midwest Status and Prospect (2012-2023)
1.4.4 South Status and Prospect (2012-2023)
1.4.5 West Status and Prospect (2012-2023)
1.5 USA Sales and Revenue ofSales and Revenue of Drug Screening (2012-2023)
1.5.1 USA Drug Screening Sales (K Units) and Growth Rate (2012-2023)
1.5.2 USA Drug Screening Revenue (Million USD) and Growth Rate (2012-2023)
2 Industrial Chain Analysis
2.1 Industry Chain Structure of Drug Screening
2.2 Raw Material Analysis of Drug Screening
2.1.1 Raw Material A Market Analysis
2.1.2 Raw Material B Market Analysis
2.1.3 Raw Material C Market Analysis
2.3 Labor Cost Analysis of Drug Screening
2.4 Other Costs Analysis of Drug Screening
2.5 Manufacturing Cost Structure Analysis of Drug Screening
2.6 Manufacturing Process Analysis of Drug Screening
2.7 Raw Materials Sources of Drug Screening Major Manufacturers in 2018
2.8 Downstream Buyers
3 USA Drug Screening Players/Suppliers Profiles and Sales Data
3.1 Alere
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Drug Screening Product Category, Application and Specification
3.1.2.1 Product A
3.1.2.2 Product B
3.1.3 Alere Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.1.4 Alere Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.1.5 Alere Drug Screening Volume in Different Applications and Its Application Share
3.2 Express Diagnostics
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Drug Screening Product Category, Application and Specification
3.2.2.1 Product A
3.2.2.2 Product B
3.2.3 Express Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.2.4 Express Diagnostics Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.2.5 Express Diagnostics Drug Screening Volume in Different Applications and Its Application Share
3.3 Laboratory Corporation of America
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Drug Screening Product Category, Application and Specification
3.3.2.1 Product A
3.3.2.2 Product B
3.3.3 Laboratory Corporation of America Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.3.4 Laboratory Corporation of America Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.3.5 Laboratory Corporation of America Drug Screening Volume in Different Applications and Its Application Share
3.4 MPD
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Drug Screening Product Category, Application and Specification
3.4.2.1 Product A
3.4.2.2 Product B
3.4.3 MPD Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.4.4 MPD Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.4.5 MPD Drug Screening Volume in Different Applications and Its Application Share
3.5 Quest Diagnostics
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Drug Screening Product Category, Application and Specification
3.5.2.1 Product A
3.5.2.2 Product B
3.5.3 Quest Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.5.4 Quest Diagnostics Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.5.5 Quest Diagnostics Drug Screening Volume in Different Applications and Its Application Share
3.6 Roche Diagnostics
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Drug Screening Product Category, Application and Specification
3.6.2.1 Product A
3.6.2.2 Product B
3.6.3 Roche Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.6.4 Roche Diagnostics Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.6.5 Roche Diagnostics Drug Screening Volume in Different Applications and Its Application Share
3.7 Shimadzu
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Drug Screening Product Category, Application and Specification
3.7.2.1 Product A
3.7.2.2 Product B
3.7.3 Shimadzu Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.7.4 Shimadzu Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.7.5 Shimadzu Drug Screening Volume in Different Applications and Its Application Share
3.8 Siemens Healthcare
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Drug Screening Product Category, Application and Specification
3.8.2.1 Product A
3.8.2.2 Product B
3.8.3 Siemens Healthcare Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.8.4 Siemens Healthcare Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.8.5 Siemens Healthcare Drug Screening Volume in Different Applications and Its Application Share
3.9 Thermo Fisher Scientific
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Drug Screening Product Category, Application and Specification
3.9.2.1 Product A
3.9.2.2 Product B
3.9.3 Thermo Fisher Scientific Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
3.9.4 Thermo Fisher Scientific Different Types of Drug Screening Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017)
3.9.5 Thermo Fisher Scientific Drug Screening Volume in Different Applications and Its Application Share
4 USA Drug Screening Competition by Players/Manufacturers, Region, Type and Application
4.1 USA Drug Screening Market Competition by Players/Manufacturers
4.1.1 USA Drug Screening Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017)
4.1.2 USA Drug Screening Revenue (Million USD) and Share by Players/Suppliers (2012-2017)
4.2 USA Drug Screening Sales and Revenue by Type
4.2.1 USA Drug Screening Sales (K Units) and Market Share by Type (2012-2017)
4.2.2 USA Drug Screening Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 USA Drug Screening Sales and Revenue by Application
4.3.1 USA Drug Screening Sales (K Units) and Market Share by Regions (2012-2017)
4.3.2 USA Drug Screening Revenue (Million USD) and Market Share (%) Regions (2012-2017)
4.4 USA Drug Screening Sales (K Units) by Application
5 Northeast Drug Screening (Sales, Revenue and Price)
5.1 Northeast Drug Screening Sales and Value (2012-2017)
5.1.1 Northeast Drug Screening Sales (K Units) and Growth Rate (2012-2017)
5.1.2 Northeast Drug Screening Revenue and Growth Rate (2012-2017)
5.1.3 Northeast Drug Screening Sales Price (USD/Unit) Trend (2012-2017)
5.2 Northeast Drug Screening Sales (K Units) and Market Share by Type
5.3 Northeast Drug Screening Sales (K Units) and Market Share by Application
6 Midwest Drug Screening (Sales, Revenue and Price)
6.1 Midwest Drug Screening Sales and Value (2012-2017)
6.1.1 Midwest Drug Screening Sales (K Units) and Growth Rate (2012-2017)
6.1.2 Midwest Drug Screening Revenue and Growth Rate (2012-2017)
6.1.3 Midwest Drug Screening Sales Price (USD/Unit) Trend (2012-2017)
6.2 Midwest Drug Screening Sales (K Units) and Market Share by Type
6.3 Midwest Drug Screening Sales (K Units) and Market Share by Application
7 South Drug Screening (Sales, Revenue and Price)
7.1 South Drug Screening Sales and Value (2012-2017)
7.1.1 South Drug Screening Sales (K Units) and Growth Rate (2012-2017)
7.1.2 South Drug Screening Revenue and Growth Rate (2012-2017)
7.1.3 South Drug Screening Sales Price (USD/Unit) Trend (2012-2017)
7.2 South Drug Screening Sales (K Units) and Market Share by Type
7.3 South Drug Screening Sales (K Units) and Market Share by Application
8 West Drug Screening (Sales, Revenue and Price)
8.1 West Drug Screening Sales and Value (2012-2017)
8.1.1 West Drug Screening Sales (K Units) and Growth Rate (2012-2017)
8.1.2 West Drug Screening Revenue and Growth Rate (2012-2017)
8.1.3 West Drug Screening Sales Price (USD/Unit) Trend (2012-2017)
8.2 West Drug Screening Sales (K Units) and Market Share by Type
8.3 West Drug Screening Sales (K Units) and Market Share by Application
11 Marketing Strategy Analysis, Distributors/Traders
11.1 Direct Marketing
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
11.2.1 Pricing Strategy
11.2.2 Brand Strategy
11.2.3 Target Client
11.3 Distributors/Traders List
12 USA Drug Screening Market Forecast (2018-2023)
12.1 USA Drug Screening Sales (K Units), Revenue and Price Forecast (2018-2023)
12.1.1 USA Drug Screening Sales (K Units) and Growth Rate Forecast (2018-2023)
12.1.2 USA Drug Screening Revenue and Growth Rate Forecast (2018-2023)
12.1.3 USA Drug Screening Price and Trend Forecast (2018-2023)
12.2 USA Drug Screening Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023)
12.2.1 USA Drug Screening Sales (K Units) and Growth Rate Forecast by Region (2018-2023)
12.2.2 USA Drug Screening Revenue and Growth Rate Forecast by Region (2018-2023)
12.2.3 Northeast Drug Screening Sales, Revenue and Growth Rate Forecast (2018-2023)
12.2.4 Midwest Drug Screening Sales, Revenue and Growth Rate Forecast (2018-2023)
12.2.5 Midwest Drug Screening Sales, Revenue and Growth Rate Forecast (2018-2023)
12.2.6 West Drug Screening Sales, Revenue and Growth Rate Forecast (2018-2023)
12.3 USA Drug Screening Sales, Revenue and Price Forecast by Type (2018-2023)
12.3.1 USA Drug Screening Sales Forecast by Type (2018-2023)
12.3.2 USA Drug Screening Revenue Forecast by Type (2018-2023)
12.3.3 USA Drug Screening Price Forecast by Type (2018-2023)
12.4 USA Drug Screening Sales Forecast by Application (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Drug-delivery Smart Pill
Drug-delivery Smart Pill
×